Symbio Generics India

Symbio Generrics India is a specialized pharmaceutical company focused on the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage forms. Headquartered in Bengaluru, the company operates state-of-the-art R&D and manufacturing facilities, including its fully owned subsidiary, VPL Chemicals. Their product portfolio spans diverse therapeutic areas such as oncology, cardiology, diabetes, and digestive health, with a strong emphasis on niche generics and specialty enzymes like pancreatin and serratiopeptidase. Symbio serves a global clientele, providing CDMO services and high-quality ingredients that meet international regulatory standards. The company is backed by private equity firm Ascent Capital and is led by a team of experienced pharmaceutical professionals.